Coached, Coordinated, Enhanced Neonatal Transition (CCENT)
NCT ID: NCT03350243
Last Updated: 2023-04-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
275 participants
INTERVENTIONAL
2018-01-31
2022-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Canadian Triage and Acuity Scale for Children; A Prospective Multi-Center Evaluation.
NCT00807352
Facilitated Referral for Children Screening Positive for Mental Illness
NCT00448331
The Implementation of a Gastroenteritis Education Program
NCT00311831
The Effect of Telehealth Ontario on Non-urgent Emergency Department Use at The Hospital for Sick Children
NCT00625027
Comparison of Thermometry in Canada for Pediatrics
NCT03147534
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
CCENT Intervention group
Participants will be assigned a dedicated key worker that will support families through the child's first year, in addition to standard medical care, which involves a primary care provider and/or neonatal follow-up at routine times.
CCENT Intervention
1. Acceptance and Commitment Therapy approach: engaging families through structured individual or group sessions within the NICU and continue this support once discharged.
2. Care coordination: supporting providers in clear communication when liaising across various levels of care as well as supporting families in system and resource navigation.
3. Anticipatory guidance: proactive education targeting normal challenges in caring for a child who required intensive care support.
Control group
Participants will receive the standard medical care at their institution, which involves a primary care provider and/or neonatal follow-up at routine times.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
CCENT Intervention
1. Acceptance and Commitment Therapy approach: engaging families through structured individual or group sessions within the NICU and continue this support once discharged.
2. Care coordination: supporting providers in clear communication when liaising across various levels of care as well as supporting families in system and resource navigation.
3. Anticipatory guidance: proactive education targeting normal challenges in caring for a child who required intensive care support.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Infant born between 27-29+6 weeks GA with ≥ 1 of the following risk factors:
i)≥ Grade III intraventricular hemorrhage with post hemorrhagic hydrocephalus ii)Retinopathy of prematurity requiring intraocular bevacizumab/ anti-vascular endothelial growth factor or laser surgery therapy iii)Requires invasive (e.g., intubated) or non-invasive (e.g., CPAP or BiPAP) at ≥ 34 weeks GA and/or supplemental oxygen at ≥ 37 weeks gestational age iv)Requires surgery for management of necrotizing enterocolitis (NEC)- stage 3
3. Infant with ≥ 2 major congenital anomalies as defined by EUROCAT(13) (e.g., congenital heart disease, spina bifida, cleft palate, etc. Not including minor congenital anomalies, e.g., dysmorphic facies), and length of stay in recruiting institution ≥ 14 days.
4. Infant with hypoxic ischemic encephalopathy (HIE) requiring therapeutic hypothermia and in the recruiting institution for ≥ 14 days.
Exclusion Criteria
2. Parent will not be involved with child's care over the entirety of the study period (2 years) (e.g., adoption).
3. Infant will be followed by an out-of-province neonatal follow-up program or lives a significant distance from the neonatal follow up program and therefore not routinely followed by the team.
4. Infant that has previously been discharged home from the NICU/hospital.
5. Decision/high likelihood of decision for act of withdrawal of care by clinical teams/families
0 Months
4 Months
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sunnybrook Health Sciences Centre
OTHER
Children's Hospital of Eastern Ontario
OTHER
MOUNT SINAI HOSPITAL
OTHER
The Ottawa Hospital
OTHER
Montreal Children's Hospital of the MUHC
OTHER
Provincial Health Services Authority
OTHER
The Hospital for Sick Children
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Julia Orkin
Staff Physician, Medical Director of the Complex Care Program
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Julia Orkin, MD
Role: PRINCIPAL_INVESTIGATOR
The Hospital for Sick Children
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
BC Children's Hospital and BC Women's Hospital & Health Centre
Vancouver, British Columbia, Canada
Children's Hospital Eastern Ontario
Ottawa, Ontario, Canada
Sunnybrook Health Sciences Centre
Toronto, Ontario, Canada
The Hospital for Sick Children
Toronto, Ontario, Canada
Mount Sinai Hospital
Toronto, Ontario, Canada
McGill University Health Centre/Montreal Children's Hospital
Montreal, Quebec, Canada
The Ottawa Hospital
Ottawa, , Canada
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Orkin J, Major N, Esser K, Parmar A, Couture E, Daboval T, Kieran E, Ly L, O'Brien K, Patel H, Synnes A, Robson K, Barreira L, Smith WL, Rizakos S, Willan AR, Yaskina M, Moretti ME, Ungar WJ, Ballantyne M, Church PT, Cohen E. Coached, Coordinated, Enhanced Neonatal Transition (CCENT): protocol for a multicentre pragmatic randomised controlled trial of transition-to-home support for parents of high-risk infants. BMJ Open. 2021 Jul 7;11(7):e046706. doi: 10.1136/bmjopen-2020-046706.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1000057100
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.